EMA Validates Bristol Myers Squibb’s Subcutaneous Nivolumab Filing
Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has accepted an extension application for a new...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Artificial Intelligence in Clinical Trials Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has accepted an extension application for a new...
The FDA has approved KRAZATI (adagrasib) in combination with cetuximab as a treatment for locally advanced or metastatic colorectal...
AriBio Co., Ltd. has partnered with Kentucky Clinical Trial Laboratory (KCTL) to enhance Alzheimer’s diseaseAlzheimer’s disease testing. This collaboration...
Over the past 30 years, there have been significant advancements in therapies and the in clinical acquisition and measurement...
CAPVAXIVE (V116) is an FDA-approved vaccine for adults to combat invasive pneumococcal disease (IPD). It targets the serotypes responsible...
Pyros Pharmaceuticals has received FDA approval for VIGAFYDE™, an oral vigabatrin solution for treating infantile spasms (IS) in pediatric...
PPD, a leader in clinical research, has received a CRO Leadership Award for the 13th consecutive year in recognition...
At the European Hematology Association Congress, Innate Pharma and Sanofi presented promising results from their Phase 1/2 study of...
Empatica, a leader in digital biomarker development, has partnered with Mobilise-D, an initiative funded by the Innovative Medicines Initiative....
Greenphire unveils a groundbreaking Patient Experience Dataset, establishing the industry’s first repository of global patient-level insights. This dataset provides...